August 10, 2017 / 7:10 PM / 9 days ago

BRIEF-Fitch says pricing power erosion pressuring U.S. generic drug makers

Aug 10 (Reuters) - Fitch: ‍

* Fitch says pricing power erosion pressuring US generic drug makers

* ‍Fitch says weaker operating outlooks for large U.S. generic drug manufacturers primarily reflect an ongoing shift in industry pricing environment​​

* Fitch says ‍continuing price pressure, delay in product launches, among others, will likely pressure margins, credit metrics for U.S. drug makers into 2018​ Source text for Eikon:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below